GK

Gregg F. Keaney

CT Cadent Therapeutics: 7 patents #4 of 23Top 20%
IP Infinity Pharmaceuticals: 6 patents #25 of 76Top 35%
EC Eisai R&D Management Co.: 3 patents #243 of 817Top 30%
ID Infinity Discovery: 2 patents #12 of 27Top 45%
NA Novartis Ag: 1 patents #2,882 of 5,128Top 60%
📍 Lexington, MA: #245 of 2,299 inventorsTop 15%
🗺 Massachusetts: #5,256 of 88,656 inventorsTop 6%
Overall (All Time): #203,795 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
11993586 Crystalline forms of potassium channel modulators Jun Xu, Wenfeng Xue 2024-05-28
11926619 Certain pladienolide compounds and methods of use John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU, Guo Zhu Zheng +20 more 2024-03-12
11767319 Crystalline forms of a selective c-kit kinase inhibitor Leonard W. Rozamus, Jonathan James Loughrey, Jaclyn Raeburn, Yuxiang Song 2023-09-26
11744823 Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same Elizabeth Kwong 2023-09-05
11542264 Heteroaromatic NMDA receptor modulators and uses thereof David R. Anderson, Robert A. Volkmann, Steven C. Leiser, Sam Malekiani, Timothy Piser 2023-01-03
10774064 Potassium channel modulators Birgitte L. Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson +6 more 2020-09-15
10752633 Heteroaromatic NMDA receptor modulators and uses thereof David R. Anderson, Robert A. Volkmann, Steven C. Leiser, Sam Malekiani, Timothy Piser 2020-08-25
10745387 Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU, Guo Zhu Zheng +19 more 2020-08-18
10717728 Potassium channel modulators Dipak Vasantrao Amrutkar, Kelly Foster, Thomas Amos Jacobsen, Martin R. Jefson, Janus S. Larsen +1 more 2020-07-21
10584131 Heteroaromatic NMDA receptor modulators and uses thereof David R. Anderson, Robert A. Volkmann, Steven C. Leiser, Sam Malekiani, Timothy Piser 2020-03-10
10351553 Potassium channel modulators Dipak Vasantrao Amrutkar, Kelly Foster, Thomas Amos Jacobsen, Martin R. Jefson, Janus S. Larsen +1 more 2019-07-16
9975886 Potassium channel modulators Dipak Vasantrao Amrutkar, Kelly Foster, Thomas Amos Jacobsen, Martin R. Jefson, Janus S. Larsen +1 more 2018-05-22
9879293 Enzymatic transamination of cyclopamine analogs Brian C. Austad, Adilah Bahadoor, Jitendra D. Belani, Somarajannair Janardanannair, Sheldon L. Wallerstein +2 more 2018-01-30
9481669 Pladienolide pyridine compounds and methods of use John Wang, Baudouin Gérard, Kenzo Arai, Xiang LIU, Guo Zhu Zheng +17 more 2016-11-01
9346769 Tetrazolones as inhibitors of fatty acid synthase Adilah Bahadoor, Alfredo C. Castro, Lawrence K. Chan, Marta Nevalainen, Vesa Nevalainen +3 more 2016-05-24
8703448 Enzymatic transamination of cyclopamine analogs Brian C. Austad, Adilah Bahadoor, Jitendra D. Belani, Somarajannair Janardanannair, Charles W. Johannes +2 more 2014-04-22
8609706 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward Holson +9 more 2013-12-17
8546432 Tetrazolones as inhibitors of fatty acid synthase Adilah Bahadoor, Alfredo C. Castro, Lawrence K. Chan, Marta Nevalainen, Vesa Nevalainen +3 more 2013-10-01
8450350 Triazoles as inhibitors of fatty acid synthase Adilah Bahadoor, Alfredo C. Castro, Lawrence K. Chan, Marta Nevalainen, Vesa Nevalainen +2 more 2013-05-28
8178690 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward Holson +9 more 2012-05-15
7928244 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners Alfredo C. Castro, Kristopher M. Depew, Michael J. Grogan, Charles W. Johannes, Edward Holson +9 more 2011-04-19